130 related articles for article (PubMed ID: 11710309)
21. Highly active antiretroviral therapy in HIV-associated pulmonary hypertension.
Barbaro G; Lucchini A; Barbarini G
Minerva Cardioangiol; 2005 Apr; 53(2):153-4. PubMed ID: 15986010
[No Abstract] [Full Text] [Related]
22. Pulmonary arterial hypertension in children.
Rosenzweig EB; Widlitz AC; Barst RJ
Pediatr Pulmonol; 2004 Jul; 38(1):2-22. PubMed ID: 15170869
[TBL] [Abstract][Full Text] [Related]
23. [Verapamil (an antagonist of calcium) and its effect on chronic pulmonary hypertension in humans].
Widimský J; Jandová R; Frídl P; Ostádal B
Cas Lek Cesk; 1982 Jun; 121(25):775-8. PubMed ID: 7116382
[No Abstract] [Full Text] [Related]
24. Impact of antiretroviral therapy among HIV-1-infected patients with pulmonary hypertension.
Torre D; Pugliese A
Clin Infect Dis; 2004 Nov; 39(10):1549-50; author reply 1550. PubMed ID: 15546099
[No Abstract] [Full Text] [Related]
25. Primary pulmonary hypertension. Case series from France.
Brenot F
Chest; 1994 Feb; 105(2 Suppl):33S-36S. PubMed ID: 8306806
[No Abstract] [Full Text] [Related]
26. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
[TBL] [Abstract][Full Text] [Related]
27. [Primary pulmonary hypertension in a female patient with HIV infection].
Arranz Caso A; Herrera Serrano L; Cuadrado Gómez LM; González Estecha A
Rev Clin Esp; 1996 Jan; 196(1):61-2. PubMed ID: 8948852
[No Abstract] [Full Text] [Related]
28. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
29. [Survival--a question of active treatment. High-dose calcium blockers in pulmonary hypertension].
Husebye ES; Wibell L
Lakartidningen; 1994 Jun; 91(26-27):2573-5. PubMed ID: 8046974
[No Abstract] [Full Text] [Related]
30. New insights into the pathogenesis and treatment of primary pulmonary hypertension.
Rudarakanchana N; Trembath RC; Morrell NW
Thorax; 2001 Nov; 56(11):888-90. PubMed ID: 11641516
[No Abstract] [Full Text] [Related]
31. [Education of patients treated with a continuous epoprostenol infusion for pulmonary hypertension].
Marlier D
Soins; 2006 May; (705 Suppl):S7-12. PubMed ID: 16771257
[No Abstract] [Full Text] [Related]
32. Medical treatment of primary pulmonary hypertension: a bridge to transplantation?
Rich S
Am J Cardiol; 1995 Jan; 75(3):63A-66A. PubMed ID: 7840057
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].
Sitbon O; Jaïs X; Le Pavec J; Degano B; Humbert M; Simonneau G
Rev Prat; 2008 Nov; 58(18):2011-8. PubMed ID: 19143272
[TBL] [Abstract][Full Text] [Related]
34. Correction: calcium-channel blockers in primary pulmonary hypertension.
Gottlieb DJ
N Engl J Med; 1992 Nov; 327(20):1458-9. PubMed ID: 1285785
[No Abstract] [Full Text] [Related]
35. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
Dickinson MG; Schölvinck EH; Boonstra A; Vonk-Noordegraaf A; Snijder RJ; Berger RM
J Heart Lung Transplant; 2009 Mar; 28(3):273-9. PubMed ID: 19285620
[TBL] [Abstract][Full Text] [Related]
36. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
[TBL] [Abstract][Full Text] [Related]
37. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
[TBL] [Abstract][Full Text] [Related]
38. New therapies for primary pulmonary hypertension.
Butt AY; Higenbottam T
Chest; 1994 Feb; 105(2 Suppl):21S-25S. PubMed ID: 8110298
[No Abstract] [Full Text] [Related]
39. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Sabo JA; Nord CP
Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257
[No Abstract] [Full Text] [Related]
40. [A case of primary pulmonary hypertension in a patient with the human immunodeficiency virus].
Marcos Sánchez F; Moreiras Jiménez JL; Fernández García S; Durán Pérez-Navarro A
An Med Interna; 1995 Aug; 12(8):408-9. PubMed ID: 8924536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
